Dietary study to investigate the nutritional effectiveness and tolerability of a ready-to-drink meal replacement

Completed

• Conditions: utritional completeness of a ready-to-drink meal replacement in healthy adults; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN66877704
• Lead Sponsor: Soylent

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2016-03-30
• Study Start: 2016-04-27
• Last Update Posted: 18 June 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Age between 18 and 40 years
2. BMI between 22 and 30 kg/m^2
3. Apparently healthy, measured by questionnaire: no reported current or previous metabolic diseases or chronic gastrointestinal disorders
4. Weight stable (no significant weight loss or gain in the past 6 months)
5. Reported alcohol consumption <= 10 units/week
6. Consumption of a normal UK diet, with the inclusion of 'junk food' at least once per week ('junk food' defined by the contracting group as take away meals, fast food, crisps, chocolate, ice cream)
7. Informed consent signed

Exclusion Criteria

1. Subject has any health conditions that would prevent them from fulfilling the study requirements, put the subject at risk, or would confound the interpretation of the study results as judged by the Principal Investigator or Study Physician
2. Subjects with a significant current or previous medical history, as assessed by questionnaire
3. Subjects with a history of eating disorders
4. Subject has gastrointestinal malabsorption (from celiac disease, colitis, surgery, etc)
5. Medication: any medication that might affect the study measurements
6. Currently taking any vitamin or mineral supplements, or having taken these within the past 3 months
7. Subject has a known allergy or sensitivity to soy containing nutritional products
8. Complete Blood Count or Comprehensive Metabolic Profile values outside normal ranges, as assessed by the study physician
9. Participating in another clinical trial
10. Pregnant or breast feeding women
11. Not willing to use appropriate contraceptive methods to avoid pregnancy during the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified